PMV Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/14/2025 | 6.48 M | $9.78 M | 0.00% | 12.56% |
| SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 3.57 M | $5.39 M | 11.14% | 6.93% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 3.51 M | $5.30 M | -3.81% | 6.80% |
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 3.47 M | $5.23 M | 105.28% | 6.72% |
| EUCLIDEAN CAPITAL LLC | 02/14/2025 | 2.63 M | $3.97 M | 0.00% | 5.09% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 2.34 M | $3.54 M | 0.00% | 4.54% |
| VANGUARD GROUP INC | 02/11/2025 | 2.14 M | $3.24 M | -6.04% | 4.16% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 2.08 M | $3.14 M | 3.39% | 4.03% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 2.08 M | $3.14 M | 0.00% | 4.03% |
| BLACKROCK, INC. | 02/07/2025 | 1.15 M | $1.73 M | 0.15% | 2.22% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 1.02 M | $1.55 M | -1.56% | 1.99% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 714,600 | $1.08 M | -4.87% | 1.39% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 539,893 | $815,238 | -23.48% | 1.05% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/14/2025 | 535,805 | $809,066 | 100.00% | 1.04% |
| CITIGROUP INC | 02/12/2025 | 514,911 | $777,516 | 0.00% | 1.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 506,986 | $765,549 | 4.95% | 0.98% |
| ALDEBARAN CAPITAL, LLC | 02/12/2025 | 502,190 | $758,307 | 14.59% | 0.97% |
| 01/29/2025 | 445,744 | $673,073 | 100.00% | 0.86% | |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 421,710 | $636,963 | -2.55% | 0.82% |
| M&T BANK CORP | 02/06/2025 | 399,548 | $603,659 | 0.00% | 0.77% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 370,920 | $560,089 | -15.90% | 0.72% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 322,024 | $486,256 | 0.00% | 0.62% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 318,020 | $480,210 | -12.62% | 0.62% |
| UBS GROUP AG | 02/14/2025 | 275,464 | $415,951 | 54.01% | 0.53% |
| RBF CAPITAL, LLC | 02/14/2025 | 245,561 | $379,967 | -3.08% | 0.48% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 202,100 | $305,171 | 44.46% | 0.39% |
| STATE STREET CORP | 02/14/2025 | 157,578 | $237,943 | 8.62% | 0.31% |
| SHAY CAPITAL LLC | 02/14/2025 | 156,451 | $236,241 | -16.80% | 0.30% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 153,701 | $232,089 | -56.56% | 0.30% |
| EVOKE WEALTH, LLC | 02/10/2025 | 133,122 | $201,014 | 0.00% | 0.26% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 127,626 | $192,715 | -12.43% | 0.25% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 126,004 | $190,238 | 0.00% | 0.24% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 121,245 | $183,080 | -76.23% | 0.24% |
| CITADEL ADVISORS LLC | 02/14/2025 | 107,888 | $162,911 | -89.78% | 0.21% |
| NORTHERN TRUST CORP | 02/14/2025 | 107,340 | $162,083 | 23.17% | 0.21% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 101,008 | $152,522 | 0.00% | 0.20% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 89,631 | $135,343 | 0.00% | 0.17% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 73,015 | $110,253 | 68.65% | 0.14% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/07/2025 | 69,113 | $104,361 | -0.17% | 0.13% |
| MARQUETTE ASSET MANAGEMENT, LLC | 01/14/2025 | 64,009 | $96,654 | 0.00% | 0.12% |
| JANE STREET GROUP, LLC | 02/14/2025 | 49,870 | $75,304 | -32.69% | 0.10% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 44,568 | $67,297 | -63.10% | 0.09% |
| MORGAN STANLEY | 02/14/2025 | 41,763 | $63,062 | -29.72% | 0.08% |
| ROYAL BANK OF CANADA | 02/14/2025 | 40,384 | $61,000 | 100.00% | 0.08% |
| HSBC HOLDINGS PLC | 02/14/2025 | 39,080 | $58,034 | 0.00% | 0.08% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 35,200 | $53,152 | -47.38% | 0.07% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 35,000 | $52,850 | 100.00% | 0.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 33,600 | $51,000 | 0.00% | 0.07% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 32,603 | $49,231 | 1.28% | 0.06% |
| BARCLAYS PLC | 02/13/2025 | 30,197 | $45,000 | -0.17% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PMV Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 90 institutional investors and hedge funds held shares of PMV Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Marquette Asset Management, LLC: 0
ORBIMED ADVISORS LLC: 6.48 M
Sio Capital Management, LLC: 3.57 M
ArrowMark Colorado Holdings LLC: 3.51 M
BML Capital Management, LLC: 3.47 M
Euclidean Capital LLC: 2.63 M
75.54% of PMV Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.50 M shares in the last 24 months. This purchase volume represents approximately $42.92 M in transactions.